408 related articles for article (PubMed ID: 26065893)
21. B-cell maturation antigen is modified by a single N-glycan chain that modulates ligand binding and surface retention.
Huang HW; Chen CH; Lin CH; Wong CH; Lin KI
Proc Natl Acad Sci U S A; 2013 Jul; 110(27):10928-33. PubMed ID: 23776238
[TBL] [Abstract][Full Text] [Related]
22. A Novel BCMA Immunohistochemistry Assay Reveals a Heterogenous and Dynamic BCMA Expression Profile in Multiple Myeloma.
Zhang M; Gray F; Cushman I; Wurmser A; Chan H; Couto S; Wang M; Nakayama Y; Hagner P; Al-Masri H; Williams S; Hersey S
Mod Pathol; 2023 Apr; 36(4):100050. PubMed ID: 36788077
[TBL] [Abstract][Full Text] [Related]
23. The role of soluble B cell maturation antigen as a biomarker in multiple myeloma.
Alomari M; Kunacheewa C; Manasanch EE
Leuk Lymphoma; 2023 Feb; 64(2):261-272. PubMed ID: 36282671
[TBL] [Abstract][Full Text] [Related]
24. Serum B-cell maturation antigen (BCMA) reduces binding of anti-BCMA antibody to multiple myeloma cells.
Chen H; Li M; Xu N; Ng N; Sanchez E; Soof CM; Patil S; Udd K; Bujarski S; Cao J; Hekmati T; Ghermezi M; Zhou M; Wang EY; Tanenbaum EJ; Zahab B; Schlossberg R; Yashar MA; Wang CS; Tang GY; Spektor TM; Berenson JR
Leuk Res; 2019 Jun; 81():62-66. PubMed ID: 31035033
[TBL] [Abstract][Full Text] [Related]
25. B-lymphocyte-induced maturation protein1 up-regulates the expression of B-cell maturation antigen in mouse plasma cells.
Deng S; Yuan T; Cheng X; Jian R; Jiang J
Mol Biol Rep; 2010 Dec; 37(8):3747-55. PubMed ID: 20339926
[TBL] [Abstract][Full Text] [Related]
26. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA.
Day ES; Cachero TG; Qian F; Sun Y; Wen D; Pelletier M; Hsu YM; Whitty A
Biochemistry; 2005 Feb; 44(6):1919-31. PubMed ID: 15697217
[TBL] [Abstract][Full Text] [Related]
27. Serum B-cell maturation antigen is elevated in multiple myeloma and correlates with disease status and survival.
Sanchez E; Li M; Kitto A; Li J; Wang CS; Kirk DT; Yellin O; Nichols CM; Dreyer MP; Ahles CP; Robinson A; Madden E; Waterman GN; Swift RA; Bonavida B; Boccia R; Vescio RA; Crowley J; Chen H; Berenson JR
Br J Haematol; 2012 Sep; 158(6):727-38. PubMed ID: 22804669
[TBL] [Abstract][Full Text] [Related]
28. Role of BAFF in Opsoclonus-Myoclonus syndrome, a bridge between cancer and autoimmunity.
Raffaghello L; Fuhlhuber V; Bianchi G; Conte M; Blaes F; Gambini C; Pistoia V
J Leukoc Biol; 2013 Jul; 94(1):183-91. PubMed ID: 23610147
[TBL] [Abstract][Full Text] [Related]
29. [Cloning, soluble expression and characterization of human sBCMA].
Guan ZB; Cao P; Ye JL; Zhang SQ
Sheng Wu Gong Cheng Xue Bao; 2006 Jan; 22(1):46-51. PubMed ID: 16572839
[TBL] [Abstract][Full Text] [Related]
30. A comparative study of adjuvants effects on neonatal plasma cell survival niche in bone marrow and persistence of humoral immune responses.
Aradottir Pind AA; Thorsdottir S; Magnusdottir GJ; Meinke A; Del Giudice G; Jonsdottir I; Bjarnarson SP
Front Immunol; 2022; 13():904415. PubMed ID: 35990686
[TBL] [Abstract][Full Text] [Related]
31. Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease.
Martone RL; Zhou H; Atchison K; Comery T; Xu JZ; Huang X; Gong X; Jin M; Kreft A; Harrison B; Mayer SC; Aschmies S; Gonzales C; Zaleska MM; Riddell DR; Wagner E; Lu P; Sun SC; Sonnenberg-Reines J; Oganesian A; Adkins K; Leach MW; Clarke DW; Huryn D; Abou-Gharbia M; Magolda R; Bard J; Frick G; Raje S; Forlow SB; Balliet C; Burczynski ME; Reinhart PH; Wan HI; Pangalos MN; Jacobsen JS
J Pharmacol Exp Ther; 2009 Nov; 331(2):598-608. PubMed ID: 19671883
[TBL] [Abstract][Full Text] [Related]
32. Identification of new Presenilin-1 phosphosites: implication for γ-secretase activity and Aβ production.
Matz A; Halamoda-Kenzaoui B; Hamelin R; Mosser S; Alattia JR; Dimitrov M; Moniatte M; Fraering PC
J Neurochem; 2015 May; 133(3):409-21. PubMed ID: 25458374
[TBL] [Abstract][Full Text] [Related]
33. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
Hales EC; Taub JW; Matherly LH
Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
[TBL] [Abstract][Full Text] [Related]
34. Plasma levels of BCMA-positive extracellular vesicles correlate to response and side effects in myeloma patients treated with belantamab-mafodotin.
Springer C; Krauter J; Trummer A
Oncotarget; 2023 Dec; 14():949-956. PubMed ID: 38039414
[TBL] [Abstract][Full Text] [Related]
35. Antibody targeting of B-cell maturation antigen on malignant plasma cells.
Ryan MC; Hering M; Peckham D; McDonagh CF; Brown L; Kim KM; Meyer DL; Zabinski RF; Grewal IS; Carter PJ
Mol Cancer Ther; 2007 Nov; 6(11):3009-18. PubMed ID: 18025285
[TBL] [Abstract][Full Text] [Related]
36. Characterization of BCMA Expression in Circulating Rare Single Cells of Patients with Plasma Cell Neoplasms.
Ndacayisaba LJ; Rappard KE; Shishido SN; Setayesh SM; Tang G; Lin P; Matsumoto N; Hsu CJ; Nevarez R; Velasco CR; Naghdloo A; Yang E; Kelly K; Hicks J; Mason J; Orlowski RZ; Manasanch EE; Kuhn P
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362214
[TBL] [Abstract][Full Text] [Related]
37. Deciphering the Exact Sequence of Endogenous Soluble B Cell Maturation Antigen and Unbiased Quantitation in Multiple Myeloma Patient Samples by LC-MS.
Shen X; Dong X; Shi J; Chen H; Lan Y; Lim AC; Xie F; Ang A; Kratzer A; Rock DA; Rock BM
Clin Chem; 2024 Jan; 70(1):339-349. PubMed ID: 38175591
[TBL] [Abstract][Full Text] [Related]
38. Purification, pharmacological modulation, and biochemical characterization of interactors of endogenous human gamma-secretase.
Winkler E; Hobson S; Fukumori A; Dümpelfeld B; Luebbers T; Baumann K; Haass C; Hopf C; Steiner H
Biochemistry; 2009 Feb; 48(6):1183-97. PubMed ID: 19159235
[TBL] [Abstract][Full Text] [Related]
39. Akt1 phosphorylates Nicastrin to regulate its protein stability and activity.
Jo EH; Ahn JS; Mo JS; Yoon JH; Ann EJ; Baek HJ; Lee HJ; Kim SH; Kim MY; Park HS
J Neurochem; 2015 Sep; 134(5):799-810. PubMed ID: 25996556
[TBL] [Abstract][Full Text] [Related]
40. Ubiquilin-1 modulates γ-secretase-mediated ε-site cleavage in neuronal cells.
Viswanathan J; Haapasalo A; Kurkinen KM; Natunen T; Mäkinen P; Bertram L; Soininen H; Tanzi RE; Hiltunen M
Biochemistry; 2013 Jun; 52(22):3899-912. PubMed ID: 23663107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
